CN1549727A - 粘膜炎莫拉氏(布拉汉氏)菌多肽及相应dna片段 - Google Patents

粘膜炎莫拉氏(布拉汉氏)菌多肽及相应dna片段 Download PDF

Info

Publication number
CN1549727A
CN1549727A CNA028169212A CN02816921A CN1549727A CN 1549727 A CN1549727 A CN 1549727A CN A028169212 A CNA028169212 A CN A028169212A CN 02816921 A CN02816921 A CN 02816921A CN 1549727 A CN1549727 A CN 1549727A
Authority
CN
China
Prior art keywords
polypeptide
seq
polynucleotide
sequence
nos
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CNA028169212A
Other languages
English (en)
Chinese (zh)
Inventor
D
D·马丁
J·哈梅尔
B·R·布罗德尔
S·理欧克斯
J·库图尔
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
ID Biomedical Corp of Washington
Original Assignee
Shire BioChem Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shire BioChem Inc filed Critical Shire BioChem Inc
Publication of CN1549727A publication Critical patent/CN1549727A/zh
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/21—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Pseudomonadaceae (F)
    • C07K14/212—Moraxellaceae, e.g. Acinetobacter, Moraxella, Oligella, Psychrobacter
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/04—Drugs for disorders of the respiratory system for throat disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/14—Antitussive agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/975—Kit

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Pulmonology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Otolaryngology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Ophthalmology & Optometry (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CNA028169212A 2001-08-27 2002-08-27 粘膜炎莫拉氏(布拉汉氏)菌多肽及相应dna片段 Pending CN1549727A (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US31463401P 2001-08-27 2001-08-27
US60/314,634 2001-08-27

Publications (1)

Publication Number Publication Date
CN1549727A true CN1549727A (zh) 2004-11-24

Family

ID=23220768

Family Applications (1)

Application Number Title Priority Date Filing Date
CNA028169212A Pending CN1549727A (zh) 2001-08-27 2002-08-27 粘膜炎莫拉氏(布拉汉氏)菌多肽及相应dna片段

Country Status (7)

Country Link
US (1) US7329500B2 (https=)
EP (1) EP1420817A1 (https=)
JP (2) JP4397233B2 (https=)
CN (1) CN1549727A (https=)
AU (1) AU2002325109C1 (https=)
CA (1) CA2457779A1 (https=)
WO (1) WO2003018052A1 (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1149164A2 (en) 1999-01-22 2001-10-31 SmithKline Beecham Biologics SA Neisseria meningitidis polypeptides

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9817824D0 (en) 1998-08-14 1998-10-14 Smithkline Beecham Biolog Novel compounds
US6673910B1 (en) * 1999-04-08 2004-01-06 Genome Therapeutics Corporation Nucleic acid and amino acid sequences relating to M. catarrhalis for diagnostics and therapeutics
US6632636B1 (en) * 1999-06-18 2003-10-14 Elitra Pharmaceuticals Inc. Nucleic acids encoding 3-ketoacyl-ACP reductase from Moraxella catarrahalis
GB9921691D0 (en) 1999-09-14 1999-11-17 Smithkline Beecham Sa Novel compounds

Also Published As

Publication number Publication date
AU2002325109B2 (en) 2008-04-10
CA2457779A1 (en) 2003-03-06
US7329500B2 (en) 2008-02-12
WO2003018052A1 (en) 2003-03-06
JP4397233B2 (ja) 2010-01-13
JP2009279003A (ja) 2009-12-03
EP1420817A1 (en) 2004-05-26
JP2005507653A (ja) 2005-03-24
US20040242859A1 (en) 2004-12-02
WO2003018052A8 (en) 2003-08-21
AU2002325109C1 (en) 2009-04-02

Similar Documents

Publication Publication Date Title
CN1191362C (zh) 新颖的链球菌抗原
CN1268745C (zh) B组链球菌抗原
CN1200731C (zh) 用作疫苗的肺炎球菌胆碱结合蛋白衍生物
CN1284965A (zh) 脑膜炎奈瑟氏球菌的新表面蛋白
CN1433471A (zh) 85kgDa奈瑟球菌的抗原
CN1473166A (zh) 犬埃里希体的同源28kD免疫优势蛋白质基因及其用途
CN1203180C (zh) 来自脑膜炎奈瑟氏球菌的basb006多核苷酸和多肽
CN1556857A (zh) 呼吸道合胞病毒(rsv)g蛋白的新肽及其在疫苗中的应用
CN1134173A (zh) 间日疟原虫和镰状疟原虫红细胞结合蛋白的结合区
CN1680434A (zh) 肺炎链球菌抗原
CN1245512C (zh) 含重组菌毛蛋白的抗淋病奈瑟氏球茵或脑膜炎奈瑟氏球菌的疫苗
CN1204253C (zh) 奈瑟氏球菌乳铁蛋白结合蛋白
CN1191851C (zh) 包含胆碱结合蛋白an－末端截取物的氨基酸的多肽、由该多肽衍生的疫苗及其应用
CN1535314A (zh) 同源性犬埃里希体28千道尔顿免疫优势蛋白质基因及其用途
CN1245419C (zh) 脑膜炎奈瑟氏球菌(Neisseria meningitidis)的多核苷酸和多肽BASB033及其用途
CN1210401C (zh) 源自粘膜炎莫拉氏菌的化合物
CN1629188A (zh) 日本血吸虫的特异性抗原及用途
CN1653084A (zh) 酶活性减少的非典型流感嗜血杆菌的p4蛋白突变体
CN1198931C (zh) 粘膜炎莫拉氏菌basb034多肽及应用
CN1549727A (zh) 粘膜炎莫拉氏(布拉汉氏)菌多肽及相应dna片段
CN101063141A (zh) 粘膜炎莫拉氏菌(布兰汉氏菌)抗原
CN1603346A (zh) 蛋白质，含有其的产品及其在诊断、治疗和/或预防sars相关疾病中的用途
CN1545552A (zh) 基因和蛋白质及它们的用途
CN1582336A (zh) 粘膜炎莫拉氏菌(布兰汉氏菌属)抗原
CN1375006A (zh) 新型化合物

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
ASS Succession or assignment of patent right

Owner name: YIDE BIOLOGICAL MEDICAL CO.,LTD.

Free format text: FORMER OWNER: SHIRE BIOCHEM INC.

Effective date: 20050408

C41 Transfer of patent application or patent right or utility model
TA01 Transfer of patent application right

Effective date of registration: 20050408

Address after: British Columbia

Applicant after: Id Biomedical

Address before: Quebec

Applicant before: Shire Biochem Inc.

C12 Rejection of a patent application after its publication
RJ01 Rejection of invention patent application after publication